Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Adamis Pharmaceuticl (NQ: ADMP)
1.390 USD  -0.030 (-2.11%)
Official Closing Price  /  Updated: 3:59 PM EDT, Jun 18, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 260,600
Open 1.420
Bid (Size) 1.300 (20)
Ask (Size) 1.530 (2)
Prev. Close 1.420
Today's Range 1.330 - 1.454
52wk Range 1.250 - 5.100
Shares Outstanding 33,389,410
Dividend Yield N/A
Performance
YTD
-41.84%
-41.84%
1 Month
-23.63%
-23.63%
3 Month
-39.83%
-39.83%
6 Month
-43.72%
-43.72%
1 Year
-63.42%
-63.42%
Featured News
More News
Adamis Enters Distribution Agreement With Novartis Unit Sandoz
Adamis Pharmaceuticals announced last night that it has entered into an exclusive distribution and commercialization agreement with Sandoz, a division of Novartis. Read More
category Stocks / Equities , Healthcare
from Blogs - TalkMarkets
Adamis Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
Adamis Pharmaceuticals Corporation announced today the pricing of its previously announced underwritten public offering of 4,285,715 shares of its common stock at a public offering price of $3.50 per... Read More
category Stocks / Equities , Healthcare
from Blogs - TalkMarkets
Featured News
Read More
Today’s Top Trending Stocks - Tuesday, Mar. 7
category Stocks / Equities
from Blogs - TalkMarkets
Morning Call For August 29, 2016
category Futures , Bonds , Commodities , and 2 more.
from Blogs - TalkMarkets
Why Is Adamis Pharmaceuticals Corporation So Hot Right Now?
category Healthcare , Stocks / Equities
from Blogs - TalkMarkets
ADMP Announces Positive Results For Its Dry Powder Inhaler Product; BOTA Commences Dosing In Vapendavir Phase 2b Trial
category Healthcare , Stocks / Equities , Pharma/Biotech
from Blogs - TalkMarkets
EnteroMedics Spikes Up Following FDA Approval Of Neuroblocking Obesity Device
category Stocks / Equities , Pharma/Biotech
from Blogs - TalkMarkets
More News
Read More
Adamis Pharmaceuticals Provides Update on Its Higher Dose Naloxone Injection Product
from GlobeNewswire News Releases
Adamis Pharmaceuticals to Present at Conferences in June 2019
from GlobeNewswire News Releases
Adamis Pharmaceuticals Announces Patent Litigation Regarding Its Higher Dose Naloxone Injection Product
from GlobeNewswire News Releases
Adamis Pharmaceuticals Announces Conditional Acceptance by FDA of Proprietary Name for Higher Dose Naloxone Product
from GlobeNewswire News Releases
Adamis Pharmaceuticals Announces First Quarter 2019 Financial Results and Business Update
from GlobeNewswire News Releases
Adamis Pharmaceuticals Schedules First Quarter 2019 Earnings Conference Call and Business Update
from GlobeNewswire News Releases
Market Trends Toward New Normal in GrafTech International, Avinger, OraSure Technologies, Adamis Pharmaceuticals, Crinetics Pharmaceuticals, and Wayside Technology Group — Emerging Consolidated Expect
from GlobeNewswire News Releases
Interesting ADMP Call Options For December 20th
category Stocks
from Market News Video
Peek Under The Hood: SPSM Has 13% Upside
category ETFs
from ETF Channel
Analysts See 18% Upside For The Holdings of SPSM
category ETFs
from ETF Channel
The Daily Biotech Pulse: Unity Biotech Licenses Anti-Aging Protein, Strong Results For Mereo's Brittle Bone Disease Drug
category IMRN , MREO , Benzinga , and 46 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.